RR,I would think that a dividend has to be years down the track...

RR,
I would think that a dividend has to be years down the track if ever.
What I am hoping to see is a positive report of the trials in Singapore i.e. a demonstration that the IP can translate to (and progress is being made towards) industrial production.
I would hope and expect that the SP will then rise, notwithstanding what can be categorised as the "shenanigans".
I expect this SP rise is a likely outcome once it appears to the market that commercial production of plasma / blood products via this method is reasonably forseeable. Until then there is likely to be no real interest in our company.
BTW whether the work and expense of bringing the product to market is undertaken by the preferred licensing arrangements with new partners or by takeover or some combination seems to me to be largely irrelevant. There is likely to be some action in the market when we get conformation the IP works on an industrial scale, simply because the demand for the end product in asia and developing markets is assured by their aspirational rising middle class and better medical care for families will obviously be high on the list of priorities after basic food and shelter.
DYOR
Kind regards,